The Blockchain Revolution: Transforming Healthcare
The blockchain is the technology powering bitcoin, as well as a myriad of services that are changing our lives.Today, there are a number of emerging use cases & applications across various sectors, including healthcare.
Quadrant Biosciences is translating science into innovative diagnostic solutions & are the team behind ClearEdge, a data-driven clinical brain health assessment toolkit that brings concussion diagnosis & treatment into the modern age. Join us for an insightful conversation,where we will dive deep into the technology supporting ClearEdge, various applications in healthcare such as data exchange & interoperability & the basics of blockchains.
~This event will fill up quickly, so make sure to secure your seat!~
6:00-6:30 pm: Networking, Light Bites,and Wine
6:30-7:00 pm: Introduction to panel & demo
7:00-7:45 pm: Panel Discussion
7:45-8:00 pm: Audience Q & A
8:00-8:30 pm: Networking & close
We are excited to announce, Dr. Aditi Joshi, Medical Director at Thomas Jefferson University Hospital, as our Guest Moderator.
Dr. Aditi Joshi is an experienced Emergency Physician working on improving healthcare through technology. Through over 3 years of working in Telemedicine on both the startup & hospital side, she has a keen interest in making technology palatable & effective for both patients, providers, & healthcare systems.As an assistant professor, she teaches medical students & residents about telemedicine & health innovation with both practical & research components, helping to hone how the future physicians think about how technology will change medical practice.She regularly contributes articles on issues of merging provider & patient needs to digital health & innovation. She speaks & teaches both students & companies on strategizing how to bridge the gap between the two worlds.Dr. Joshi is on the board of Squlptr, a healthcare app helping patients find the right local physicians for surgical procedures.
Rich Uhlig, Founder & CEO
is the Founder & CEO of Quadrant Biosciences He has more than 29 years of business experience with a focus on leading start-up & high-growth businesses. Previously, Mr. Uhlig served as the Chairman & Chief Executive Officer of Morgan Stanley Bank, the principal banking subsidiary of Morgan Stanley, where he engineered the growth of the bank from $8 billion to $35 billion in less than two years. Prior to Morgan Stanley, Mr. Uhlig was the Chief Investment Officer for Merrill Lynch Bank USA, building & managing a $65 billion proprietary trading portfolio. Prior to Merrill Lynch, Mr. Uhlig served as a Managing Director at Deutsche Bank AG where he was a bond trader & the Co-Head of the Mortgage-Backed Securities Department for the Americas & Asia. Earlier in his career, Mr. Uhlig was an investment banker at Lehman Brothers & Goldman, Sachs & Co. Mr. Uhlig is a graduate of Cornell University.
Ben Perry, Vice President of Technology at Quadrant Biosciences
Ben's career in technology encompasses a wide breadth of expertise in software development, including enterprise web applications, cloud computing, & human-computer interaction. During his experience as both a senior developer & project manager, Ben has led projects involving crowdsourced metadata curation, inventory control tools, & identity management solutions. Prior to joining Quadrant Biosciences, Ben has developed software for the federal statistical system & public opinion domain. He received his Master's degree in Information Science from Cornell University.
Dr. Steven Hicks, MD, PhD
Steve is an Assistant Professor of Academic General Pediatrics at Pennsylvania State College of Medicine in Hershey, PA. He is a physician-scientist who studies the influence of genetics & the environment on pediatric diseases involving growth andneurodevelopment.
Special thanks to our sponsors!